We are live on ! Find out more
CDTX

Cidara Therapeutics

Delisted

CDTX was delisted on the 6th of January, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
BB
1
BB Biotech
Switzerland
$15.6M +$7.28M +48,000 +72%
PM
2
Prosight Management
Texas
$11.2M +$12.5M +82,394 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$10M
IVM
4
InterWest Venture Management
California
$9.23M
FM
5
Frazier Management
Washington
$8.92M
AC
6
Aisling Capital
New York
$6.94M
BC
7
Broadfin Capital
New York
$5.83M +$281K +1,850 +5%
GPP
8
Great Point Partners
Connecticut
$5.44M +$6.07M +40,000 New
Millennium Management
9
Millennium Management
New York
$4.04M -$83.7K -552 -2%
Vanguard Group
10
Vanguard Group
Pennsylvania
$3.85M +$97.7K +644 +2%
OFM
11
Omega Fund Management
Massachusetts
$3.03M
RSCM
12
Rock Springs Capital Management
Maryland
$2.04M
TCM
13
Tekla Capital Management
Massachusetts
$1.95M
PVI
14
Pura Vida Investments
New York
$1.87M +$2.09M +13,750 New
DCM
15
DAFNA Capital Management
California
$1.47M +$60.2K +397 +4%
Renaissance Technologies
16
Renaissance Technologies
New York
$1.22M +$282K +1,860 +26%
EAM
17
Eventide Asset Management
Massachusetts
$1.17M -$698K -4,600 -35%
GC
18
Guggenheim Capital
Illinois
$701K -$138K -911 -15%
WFI
19
West Family Investments
California
$680K
Alyeska Investment Group
20
Alyeska Investment Group
Illinois
$664K
BCM
21
Bridgeway Capital Management
Texas
$639K +$190K +1,250 +36%
Deutsche Bank
22
Deutsche Bank
Germany
$543K -$751K -4,952 -55%
Jacobs Levy Equity Management
23
Jacobs Levy Equity Management
New Jersey
$503K +$181K +1,193 +48%
BlackRock
24
BlackRock
New York
$465K +$12.3K +81 +2%
TMC
25
Trellus Management Company
Florida
$415K +$159K +1,048 +52%